NEWS

African Medicines Agency inaugurates Technical Committees

October 26, 2026

The seven Technical Committees of the African Medicines Agency (AMA) were inaugurated in Kigali today. 

Established by the AMA Treaty, the Technical Committees review the scientific evidence in applications for medical products, including medicines, vaccines and diagnostics, and for clinical trials, and give AMA independent scientific advice. Their guidance will support AMA’s work with national regulators to improve access to quality, safe and effective medical products for patients across Africa.

Their areas of work include the evaluation of medicines, vaccines and biologicals, clinical trials oversight, market intelligence and control, quality control laboratories, vigilance, regulatory inspections, and medical devices, diagnostics and emerging technologies. 

“Today is an important day for AMA. With the inauguration of our Technical Committees, we are building an African regulatory institution that belongs to Africa, serves Africa and contributes confidently to the world. These experts bring the scientific rigour that underpins our work, in support of regulators across the continent and the patients who depend on them.” – H.E Dr. Delese Mimi Darko, Director-General, African Medicines Agency

“The Technical Committees have been entrusted with a highly important mission, which is to help build a regulatory system that is efficient, coherent, transparent and at the service of the population. Their members bring skills, experience and integrity that will be used to protect the health of Africa.” – Dr. Yossounon Chabi, Chair, AMA Governing Board

Members were selected through an open, competitive and merit-based process, following a continent-wide call for expressions of interest. They serve as individual experts in an independent scientific capacity. 

AMA Week runs from 25 to 30 October 2026 in Kigali. Activities include the launch of two AMA Hubs and the 11th African Medicines Regulators Conference, co-convened with WHO.

AMA and EMA Issue Joint Guidance on Ebola Vaccine Development

Media Contacts:

AMA

African Medicines Agency

Julius Bizimungu

amacomms@au-ama.africa